New drug cocktail aims to keep myeloma in check after transplant
NCT ID NCT02253316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a three-drug combination (ixazomib, lenalidomide, and dexamethasone) given after a stem cell transplant to people with multiple myeloma. The goal is to see if this treatment can keep the cancer away longer. After four rounds, participants are randomly assigned to take either ixazomib or lenalidomide as long-term maintenance therapy. The study involves 236 adults aged 18 to 70.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Emory University - Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
Washington University School of Medicine
St Louis, Missouri, 62864, United States